Top Markets
Coin of the day
TMS Co., Ltd. TMS Co., Ltd.

TMS Co., Ltd.

4891
Classifica tra le azioni #27373
Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on... Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceuticals, quasi-drugs, drug substances, medical devices, and various medical commodities. The company's pipeline includes TMS-007, an SMTP congener demonstrating both prothrombolytic and anti-inflammatory/antioxidative activities, which has advanced through Phase 2a clinical trials for the treatment of acute ischemic stroke. Additionally, TMS-008, another SMTP congener with anti-inflammatory/antioxidative properties, is undergoing nonclinical development for addressing inflammatory complications like acute kidney injury and cancer cachexia. A third product candidate, TMS-009, is currently in preclinical development. TMS Co., Ltd. collaborates with Hokkaido University and Kanazawa University to assess the potential of its drug candidates, has a joint research agreement with Teikyo University to identify renal function biomarkers, and maintains a strategic alliance with Ji Xing Pharmaceuticals Limited.
Prezzo delle azioni
$0.73072946
Capitalizzazione di mercato
$33.30M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-31.85%
Paese
JP
Scambia TMS Co., Ltd. (4891)

Categoria

Storico del rendimento da dividendi per TMS Co., Ltd. (4891)
Il rendimento da dividendi (TTM) di TMS Co., Ltd. (simbolo azionario: 4891) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per TMS Co., Ltd. (4891) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH